The Link between Three Single Nucleotide Variants of the GIPR Gene and Metabolic Health

Genes (Basel). 2022 Aug 26;13(9):1534. doi: 10.3390/genes13091534.

Abstract

Single nucleotide variants (SNVs) of the GIPR gene have been associated with BMI and type 2 diabetes (T2D), suggesting the role of the variation in this gene in metabolic health. To increase our understanding of this relationship, we investigated the association of three GIPR SNVs, rs11672660, rs2334255 and rs10423928, with anthropometric measurements, selected metabolic parameters, and the risk of excessive body mass and metabolic syndrome (MS) in the Polish population. Normal-weight subjects (n = 340, control group) and subjects with excessive body mass (n = 600, study group) participated in this study. For all participants, anthropometric measurements and metabolic parameters were collected, and genotyping was performed using the high-resolution melting curve analysis. We did not find a significant association between rs11672660, rs2334255 and rs10423928 variants with the risk of being overweight. Differences in metabolic and anthropometric parameters were found for investigated subgroups. An association between rs11672660 and rs10423928 with MS was identified. Heterozygous CT genotype of rs11672660 and AT genotype of rs10423928 were significantly more frequent in the group with MS (OR = 1.38, 95%CI: 1.03-1.85; p = 0.0304 and OR = 1.4, 95%CI: 1.05-1.87; p = 0.0222, respectively). Moreover, TT genotype of rs10423928 was less frequent in the MS group (OR = 0.72, 95%CI: 0.54-0.95; p = 0.0221).

Keywords: GIP; GIPR gene; metabolic health; metabolic syndrome; obesity; single nucleotide variant.

MeSH terms

  • Alleles
  • Diabetes Mellitus, Type 2* / epidemiology
  • Genotype
  • Humans
  • Metabolic Syndrome* / genetics
  • Polymorphism, Single Nucleotide
  • Receptors, Gastrointestinal Hormone* / genetics

Substances

  • Receptors, Gastrointestinal Hormone

Grants and funding

This research was funded by Poznan University of Medical Sciences from the internal funds of the Department of Treatment of Obesity, Metabolic Disorders and Clinical Dietetics.